CA 15.3 as a signal of undetectable breast cancer metastases in a follow-up period of 4 years
- 1 January 1992
- journal article
- letter
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 7 (1) , 59-60
- https://doi.org/10.1177/172460089200700109
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate AntigensAdvances in Cancer Research, 1989
- Value of CA 15:3 in the follow-up of breast cancer patientsBritish Journal of Cancer, 1987
- Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.Journal of Clinical Oncology, 1986
- Circulating Ca 15.3 Levels in Breast Cancer. Our Present ExperienceThe International Journal of Biological Markers, 1986
- Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast TumorsHybridoma, 1984